- 24/7 Wall St.•9 hours ago
A recent research report from the biotech team at Baird offers their top picks for 2017. While hardly pounding the table, they are cautiously optimistic on the industry.
- Zacks•9 hours ago
We expect biotech company Vertex Pharmaceuticals, Inc. (VRTX) to beat expectations when it reports fourth-quarter 2016 and full-year earnings results on Jan 25, after the market closes.
- Accesswire•9 hours agoBlog Coverage Paratek Announced Enrollment Completion in Omadacycline Phase-3 Community-Acquired Bacterial Pneumonia Study
Upcoming AWS Coverage on Vertex Pharmaceuticals Post-Earnings Results LONDON, UK / ACCESSWIRE / January 19, 2017 / Active Wall St. blog coverage looks at the headline from Paratek Pharmaceuticals, Inc. ...
VRTX : Summary for Vertex Pharmaceuticals Incorpor - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||77.00 x 200|
|Ask||81.74 x 100|
|Day's Range||80.51 - 82.67|
|52 Week Range||71.46 - 103.73|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-71.35|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|